Patients with with recurrent or progressive medulloblastoma, ependymoma, atypical teratoid rhabdoid tumor (ATRT), and CNS tumors of various histologies have a …

Medulloblastoma RecurrentEpendymoma RecurrentATRT Recurrent+1 more

~Estimated

~$10 – $6,250

Medical University of ViennaNCT01356290

Phase 1

JACOB: Joint Administration of cDNA for TP53, checkpOint Inhibition and Boost/Hypofractionated Radiation. A Phase 0/1 Study in Children With Recurrent, Progressive or Refractory CNS Malignancies.

This clinical trial is studying a drug called SGT-53 along with radiation and another drug called Nivolumab. It's for children with brain tumors that have come…

CNS MalignanciesMedulloblastoma RecurrentATRT Recurrent+4 more

~Estimated

~$10 – $5,625

Children's National Research InstituteNCT07017816